View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Oliver Dunvold
  • Petter Haugen

Higher TP on higher earnings

We make only minor adjustments to our estimates. ABGSCe 33% above cons. EBITDA for 2025e. TP of NOK 112 (108) – BUY reiterated.

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland

Ready to increase its too low leverage

Over collection expected from increased legal costs. Cash EBITDA down 5% for 2024e-25e on ERC. Ready to invest more and increase its too low leverage. BUY.

 PRESS RELEASE

Uniti Group Inc. to Participate at the J.P. Morgan 52nd Annual Global ...

Uniti Group Inc. to Participate at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference LITTLE ROCK, Ark., May 15, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, and Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference on May 22, 2024 in Boston, MA. Any investor materials will be made available on Uniti’s Investor Relations website at u...

 PRESS RELEASE

Cidara Therapeutics Provides Corporate Update and Reports First Quarte...

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2024, and provided an update on its corporate activities and product pipeline. “Our reacquisition of our CD388 progr...

 PRESS RELEASE

OMNIQ REPORTS SIGNIFICANT FINANCIAL IMPROVEMENTS FOCUSING ON PROFITABI...

OMNIQ REPORTS SIGNIFICANT FINANCIAL IMPROVEMENTS FOCUSING ON PROFITABILITY AND OPERATIONAL EFFICIENCY IN Q1 2024 EARNINGS Salt Lake City, May 15, 2024 (GLOBE NEWSWIRE) -- omniQ Corporation (OTC PINK: OMQS) ("omniQ" or "the Company"), a leading provider of Artificial Intelligence (AI)-based solutions, today reported substantial progress towards achieving financial stability in its quarterly earnings for Q1 2024. The Company has demonstrated a commendable reduction in operational costs and enhanced sales performance, underscoring its commitment to excellence and shareholder value. FINANC...

ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Oliver Dunvold
  • Petter Haugen

Another example of the power of dividends

Minor estimate changes. ABGSC '24e EBITDA 9% above cons. TP NOK 188 (196) – P/NAV 1.11x

 PRESS RELEASE

Victoria’s Secret & Co. Invites You to Listen to the First Quarter 202...

Victoria’s Secret & Co. Invites You to Listen to the First Quarter 2024 Earnings Call Webcast REYNOLDSBURG, Ohio, May 15, 2024 (GLOBE NEWSWIRE) -- In conjunction with the Victoria’s Secret & Co. (NYSE: VSCO) first quarter 2024 earnings release, which will cross the wire after market close on Wednesday, June 5th, you are invited to listen to a live webcast of the conference call on Thursday, June 6th at 8:00 a.m. ET with Victoria’s Secret & Co. executives. What:Victoria’s Secret & Co. First Quarter 2024 Earnings Conference Call Webcast  When:8:00 a.m. ET on Thursday, June 6th, 2024  Where:...

 PRESS RELEASE

Yum! Brands, Inc. Declares Quarterly Dividend of $0.67 Per Share and A...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Yum! Brands, Inc. (NYSE: YUM) Board of Directors declared a dividend of $0.67 per share of common stock. The quarterly dividend will be distributed June 7, 2024 to shareholders of record at the close of business on May 28, 2024. Yum’s Board of Directors also approved a new share repurchase authorization which authorizes repurchases of up to $2.0 billion in shares of common stock from July 1, 2024, through December 31, 2026. The prior outstanding authorization approved in September 2022 expires on June 30, 2024. Yum! Brands, Inc., based in Louisville, Kent...

 PRESS RELEASE

Clarus Announces Upcoming Investor Conference Schedule

Clarus Announces Upcoming Investor Conference Schedule SALT LAKE CITY, May 15, 2024 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, announced today that Chief Financial Officer Mike Yates will be participating in the following investor conferences: 24th Annual B. Riley Institutional Investor Conference on Wednesday, May 22, 2024 in Beverly Hills, CA.Stifel Cross Sector Insight Conference on Tuesday, June 4, 2024 in Boston, MA. Company presentation timing is 3:35 – 4:05 PM ET.Jefferies Consu...

 PRESS RELEASE

O-I Glass Appoints John Humphrey as Independent Board Chair

O-I Glass Appoints John Humphrey as Independent Board Chair Gordon Hardie’s Appointment as CEO Effective Today PERRYSBURG, Ohio, May 15, 2024 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (“O-I”) (NYSE: OI) today announced that, after the conclusion of O-I’s Annual Meeting of Share Owners held earlier today, the Board appointed John Humphrey as the new Independent Board Chair, following the previously announced retirement of John H. Walker from the Board. Additionally, at the Annual Meeting, 10 director nominees were elected for one-year terms, including Gordon J. Hardie, whose appointment as Chi...

 PRESS RELEASE

Fortress Biotech Reports First Quarter 2024 Financial Results and Rece...

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025 FDA accepted New Drug Application filing for DFD-29 to treat inflammatory lesions and erythema of rosacea in adults; PDUFA goal date of November 4, 2024 MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring ...

 PRESS RELEASE

MRC Global Announces S&P Upgrade in Credit Rating To “B” from “B–”, Ou...

MRC Global Announces S&P Upgrade in Credit Rating To “B” from “B–”, Outlook Stable HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), (the “Company”), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy, industrial and gas utilities end-markets, today announced the Company’s issuer credit rating has been upgraded to “B” from “B–” by S&P Global Ratings (“S&P”). S&P based its ratings upgrade in part due to the Company’s ability to address its upcoming Term Loan B maturity with cash on hand, expected str...

 PRESS RELEASE

Uniti Group Inc. to Participate at the Barclays 2024 Leveraged Finance...

Uniti Group Inc. to Participate at the Barclays 2024 Leveraged Finance Conference LITTLE ROCK, Ark., May 15, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Senior Vice President, Chief Financial Officer and Treasurer, Paul Bullington, and Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the Barclays 2024 Leveraged Finance Conference on May 21, 2024 in Austin, TX. Any investor materials will be made available on Uniti’s Investor Relations website at under the Events & Presentations tab. ABOUT UNITI...

 PRESS RELEASE

Marker Therapeutics Reports First Quarter 2024 Financial Results and P...

Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response nine months after MT-601 treatment Company received approval from United States Adopted Name (USAN) council and International Nonproprietary Names (INN) expert committee for “neldaleucel” as nonproprietary name for ...

 PRESS RELEASE

Amalgamated Financial Corp. Commits Additional $85 Million to Finance ...

Amalgamated Financial Corp. Commits Additional $85 Million to Finance R-PACE Assessments NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Amalgamated Financial Corp. (“Amalgamated” or the “Company”) (Nasdaq: AMAL) announced that the Company has extended its commitment to invest in Residential Property Assessed Clean Energy (“R-PACE”) assessments through its ongoing partnership with Home Run Finance (“HRF”). Amalgamated’s commitment provides an additional $85 million of capital to fund R-PACE assessments originated by HRF. Priscilla Sims Brown, President and Chief Executive Officer, commented, ...

 PRESS RELEASE

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT 1-for-5 reverse stock split to become effective as of the opening of trading onMay 20, 2024 Rutherford, NJ, May 15, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will effect a 1-for-5 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock (the “Common Stock”), effective with the opening of trading on Monday, May 20...

 PRESS RELEASE

Jamf announces new tailored solutions aimed at empowering managed serv...

Jamf announces new tailored solutions aimed at empowering managed service providers New offerings will help managed service providers better serve their customers with Jamf MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Today, (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced it is rolling out new offerings to better support managed service provider (MSP) partners. Jamf announced Jamf Insights, a single dashboard to provide a multi-tenanted view of an entire customer estate, and the Jamf Service Provider plan, a comprehensive plan that brings together Jamf p...

 PRESS RELEASE

INVO Reports Record First Quarter 2024 Financial Results

INVO Reports Record First Quarter 2024 Financial Results 353% Revenue Growth with improvement in Adjusted EBITDA SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intravaginal culture ("IVC") procedure enabled by its INVOcell® medical device, today announced financial results for the first quarter of 2024 and provided a business update. Q1 2024 Finan...

 PRESS RELEASE

Matthews International to Participate in B. Riley Securities 24th Annu...

Matthews International to Participate in B. Riley Securities 24th Annual Institutional Investor Conference PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- (NASDAQ GSM: MATW) today announced that the company is scheduled to participate in B. Riley Securities 24th Annual Institutional Investor Conference to be held at the Beverly Hilton Hotel in Beverly Hills, CA, on Wednesday, May 22, 2024. The presentation materials utilized during the conference will be available on the investor relations website of Matthews’ website at Joe Bartolacci, President and CEO, and Steve Nicola, CFO, will b...

 PRESS RELEASE

Qurate Retail Announces Semi-Annual Interest Payment and Regular Addit...

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Qurate Retail, Inc. ("Qurate Retail") (Nasdaq: QRTEA, QRTEB, QRTEP) today announced the payment of a semi-annual interest payment and Regular Additional Distribution to the holders as of May 1, 2024 of the 4.0% Senior Exchangeable Debentures due 2029 (the "Debentures") issued by its wholly-owned subsidiary, Liberty Interactive LLC (“LI LLC”). The semi-annual interest payment amount is $20.00 per $1,000 original principal amount of Debentures (a “Debenture”), and the amount of the Regular Additional Distribution is $0.4302 per $1,000 original principal amount...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch